The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration.
Alachua, FL, United States.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely AGTC is implementing good security practices.
Read more about the latest issues in cybersecurity
The Gramm-Leach-Bliley Act (GLBA, GLB Act or the Financial Services Modernization Act of 1999) is a ...
Email spoofing is the creation of emails with a forged sender address. Because core email protocols ...
Compare AGTC's security performance with other companies